We are disrupting the $10 billion U.S. medical apparel market ($25-$45 billion globally) via the industry's first contemporary, Antimicrobial-finished products. This sleepy market has seen little innovation through the years (just ask a nurse if she likes her current scrubs) and studies show that over 90% of scrubs carry bacteria and cross-contaminate. Our 1) proprietary Antimicrobial-finished fabric, 2) flattering design aesthetics and 3) vertically integrated B2C offering have quickly changed the game.
We were founded by a seasoned consumer Private Equity investor, an influential Pediatrician and a senior Designer who worked for the industry's largest and private equity-backed medical apparel company. Our Co-Founders come from the space and leverage relationships from their family's 35+ year successful apparel company.